| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06571825 | RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR | Acute Myeloid Leukemia | Recruiting |
| Phase 1 | |||
| NCT06084962 | A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple… | Relapse/Refractory Multiple Myeloma | Recruiting |
| NCT06809699 | Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell… | Hematologic Diseases | Recruiting |
| NCT06809712 | Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell… | Hematologic Disease | Recruiting |
| Early Phase 1 | |||
| NCT04283006 | A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid… | Relapsed and Refractory | Recruiting |
| NCT04227015 | A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06785519 | CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis | Lupus Nephritis | Recruiting |
| NCT06120166 | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment… | Diffuse Large B-cell Lymphoma | Recruiting |
| Not specified | |||
| NCT06162338 | A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of… | Gaucher Disease Type I | Recruiting |
| NCT06879470 | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma | B-Non Hodgkin Lymphoma | Not Yet Recruiting |
| NCT06887985 | JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs) | Autoimmune Diseases | Not Yet Recruiting |
| NCT06902025 | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia | B-ALL | Not Yet Recruiting |